Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has purchased 310,739 of its ordinary shares on March 3, 2026, as part of its $250 million share repurchase program. The average price paid per share was 1,253.36 pence, with the lowest at 1,235.00p and the highest at 1,272.00p. These repurchased shares are intended for cancellation. Since the program's inception on February 26, 2026, Hikma has bought back 782,739 shares for £10.1 million. Following these transactions, the company holds 12,833,233 shares in treasury, with 221,103,714 ordinary shares currently in issue.

Disclaimer*

UK 100

Latest directors dealings